Cost effectiveness of fluticasone and budesonide in patients with moderate asthma.
- 1 January 1998
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 16 (2) , 117-123
- https://doi.org/10.2165/00044011-199816020-00004
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhaled Steroids and the Risk of Hospitalization for AsthmaJAMA, 1997
- Impact of Fluticasone Propionate Powder on Health-Related Quality of Life in Patients with Moderate AsthmaJournal of Asthma, 1997
- National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma CareAmerican Journal of Respiratory and Critical Care Medicine, 1996
- The costs of asthmaEuropean Respiratory Journal, 1996
- Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine, 1995
- Cost Effectiveness of Inhaled Corticosteroid plus Bronchodilator Therapy versus Bronchodilator Monotherapy in Children with AsthmaPharmacoEconomics, 1993
- Measuring Quality of Life in AsthmaAmerican Review of Respiratory Disease, 1993
- An Economic Evaluation of Asthma in the United StatesNew England Journal of Medicine, 1992
- Evaluation of the burden of illness for pediatric asthmatic patients and their parents.1991
- The cost of asthma in New South WalesThe Medical Journal of Australia, 1991